Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital

被引:57
作者
Sattler, CA
Mason, EO
Kaplan, SL
机构
[1] Texas Childrens Hosp, Infect Dis Lab, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
关键词
D O I
10.1086/317473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To describe Stenotrophomonas maltophilia infection in children, we reviewed the medical records of patients with isolates from nonrespiratory sites and identified 85 episodes, 51 (60%) of which represented true infection. Forty-two episodes (82.4%) were hospital acquired. Commonly associated with S. maltophilia infection were underlying illness (in 90.2% of cases), previous hospitalizations (in 78.7%), previous antibiotic exposure (in 78.4%), and the presence of a central venous catheter (in 76.5%). Polymicrobial isolates were obtained in 70.6% of episodes; Pseudomonas aeruginosa and Acinetobacter species were the most common coisolates. Bloodstream infection was the most frequent clinical syndrome (32 [63%] of 51 episodes). Fever or sepsis occurred in 22 (69%) and shock in 10 (31%) of 32 episodes. Infection at other sites was less severe. The most active antibiotics in vitro were trimethoprim-sulfamethoxazole and ticarcillin-clavulanate. The overall and attributable mortality rates were 12.5% and 6.3%, respectively. S. maltophilia appears to be an important cause of nosocomially acquired bacteremia in children. The significance in children of isolation from other sites is less clear.
引用
收藏
页码:1321 / 1330
页数:10
相关论文
共 81 条
[1]  
AGGER WA, 1986, REV INFECT DIS, V8, P927
[2]   Multiple antibiotic resistance in Stenotrophomonas maltophilia [J].
Alonso, A ;
Martinez, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1140-1142
[3]   BACTEREMIA AT A DANISH UNIVERSITY HOSPITAL DURING A 25-YEAR PERIOD (1968-1992) [J].
ARPI, M ;
RENNEBERG, J ;
ANDERSEN, HK ;
NIELSEN, B ;
LARSEN, SO .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1995, 27 (03) :245-251
[4]   STENOTROPHOMONAS MALTOPHILIA IN CYSTIC-FIBROSIS PATIENTS [J].
BALLESTERO, S ;
VIRSEDA, I ;
ESCOBAR, H ;
SUAREZ, L ;
BAQUERO, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) :728-729
[5]   PUNCTURE WOUND OSTEOCHONDRITIS OF THE FOOT CAUSED BY PSEUDOMONAS-MALTOPHILIA [J].
BALTIMORE, RS ;
JENSON, HB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (02) :143-144
[6]  
BERBARI N, 1993, HEART LUNG, V22, P282
[7]   EFFECT OF MEDIA COMPOSITION ON THE SUSCEPTIBILITY OF XANTHOMONAS-MALTOPHILIA TO BETA-LACTAM ANTIBIOTICS [J].
BONFIGLIO, G ;
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (06) :837-842
[8]   Sinusitis in neurologically impaired children [J].
Brook, I ;
Shah, K .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1998, 119 (04) :357-360
[9]   Xanthomonas maltophilia infection presenting as erythematous nodules [J].
Burns, RL ;
Lowe, L .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (05) :836-838
[10]   Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: A historical cohort study [J].
Carmeli, Y ;
Samore, MH .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1131-1134